Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | – | $14,229 | $12,604 | $13,498 |
| - Cash | $10,792 | $1,037 | $5,361 | $7,091 |
| + Debt | $0 | $20 | $94 | $19 |
| Enterprise Value | – | $13,211 | $7,337 | $6,426 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$119 | -$186 | -$183 | -$118 |
| % Margin | – | – | – | – |
| EBITDA | -$7,065 | -$5,983 | -$8,190 | -$17,430 |
| % Margin | – | – | – | – |
| Net Income | -$7,186 | -$6,170 | -$8,374 | -$17,549 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.27 | -1.93 | -2.93 | -8.37 |
| % Growth | 34.2% | 34.1% | 65% | – |
| Operating Cash Flow | -$7,322 | -$4,890 | -$6,636 | -$12,279 |
| Capital Expenditures | $0 | $0 | $0 | -$6 |
| Free Cash Flow | -$7,322 | -$4,890 | -$6,636 | -$12,285 |